Helping Individuals, Providers, and Health Plans Prevent Type 2 Diabetes Before It Starts
Smarter prevention. Stronger engagement. Measurable outcomes.
Glyra by Q2i is a next-generation diabetes prevention platform designed to stop the progression from prediabetes to Type 2 diabetes, where prevention has the greatest clinical and financial impact.
By combining AI-powered behavioral intelligence, continuous glucose insights, and proven incentive-based reinforcement, Glyra turns small daily actions into sustainable habits that measurably reduce diabetes risk.
How Glyra Works
Turning Daily Actions Into Measurable Prevention
Diabetes prevention fails not because the science is unclear, but because traditional programs struggle with low engagement, generic guidance, delayed feedback, and limited visibility into what's actually working.


Continuous Insight
Glyra integrates continuous glucose monitoring (CGM) with behavioral and engagement data to detect early metabolic risk and real-time behavior patterns.

Personalized Guidance
An AI-powered contextual agent delivers daily, just-in-time guidance tailored to each person's habits, routines, and emotional state.

Adaptive Reinforcement
Users earn immediate, tangible rewards for completing healthy behaviors. When engagement declines, the system intelligently pivots goals.

Measurable Outcomes
Activity, weight, sleep, nutrition patterns, and metabolic trends are continuously tracked with clear, actionable reporting.
Individuals
Prevention That Fits Real Life and Feels Rewarding
Most people with prediabetes want to make healthier choices but struggle with motivation, time, and unclear guidance. Glyra closes that gap with personalized, daily support that makes prevention simple and achievable.
With Glyra, individuals benefit from:
- Personalized, AI-guided daily actions tailored to habits, routines, and emotional context
- Clear, manageable goals instead of overwhelming lifestyle changes
- Immediate, tangible rewards for completing healthy behaviors
- Support for activity, nutrition, sleep, weight tracking, and medication adherence
- Real-time feedback that helps habits become self-sustaining
The result: improved energy, better sleep, meaningful weight reduction, and measurable decreases in diabetes risk without burnout or complexity.
Start Your Prevention Journey
Providers
Better Outcomes Without Adding to Your Workload
Primary care teams are stretched thin, and diabetes prevention often gets deprioritized. Glyra supports patients between visits while giving providers actionable insights, not more data to manage.
With Glyra, providers benefit from:
- Offload daily engagement, coaching, and monitoring to a digital system
- Identify which patients are improving, plateauing, or at risk at a glance
- Track key prevention indicators including activity, weight, sleep, nutrition, and engagement
- Reduce preventable utilization and downstream complications
- Improve performance in ACOs, PCMH models, and value-based contracts
Glyra improves outcomes, supports quality measures, and reduces clinician burden without increasing administrative workload.
See How Glyra Supports Your Patients
Health Plans
Measurable Cost Avoidance and Risk Reduction
Type 2 diabetes is one of the most expensive chronic conditions and one of the most preventable. Glyra enables health plans to intervene early, reduce conversions, and stabilize long-term risk.
With Glyra, health plans benefit from:
- Prevent progression from prediabetes to Type 2 diabetes
- Reduce long-term medical and pharmacy costs
- Improve HEDIS and CMS Star performance
- Advance population health and health equity initiatives
- Increase member engagement and satisfaction
- Ensure incentive compliance, traceability, and financial stewardship
For plans operating under thin margins and risk-based contracts, Glyra delivers one of the strongest ROI profiles in population health.
Discuss Cost-Effective Diabetes Prevention
Employers
A Smarter Investment in Workforce Health and Productivity
Diabetes drives absenteeism, presenteeism, disability risk, and rising healthcare costs. Glyra helps employers intervene early before diabetes impacts performance and benefits spend.
With Glyra, employers benefit from:
- Reduce high-cost medical and pharmacy claims
- Improve employee energy, focus, and resilience
- Decrease sick days and long-term disability risk
- Reach diverse workforces with a digital-first solution
- Gain real-time reporting on engagement and outcomes
- Deploy a fully managed program with minimal HR lift
Glyra delivers measurable productivity gains while supporting a healthier, more engaged workforce.
Talk to Us About Corporate Wellness Impact
About Q2i
The Science Behind Sustainable Behavior Change
Q2i is a healthcare technology company focused on solving complex, high-cost health challenges through behavioral science, data, and intelligent system design.
Glyra is built on proven principles of contingency management, behavioral economics, and continuous risk monitoring, integrating AI-driven contextual coaching with continuous glucose insights to deliver real-time, adaptive prevention support.
Make prevention work in the real world—at scale, across populations, and with outcomes that matter.


Address
401 Wilshire Blvd, 12th floor, Santa Monica, CA 90401


